Effects of atomoxetine on cognitive function in schizophrenia
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2007
At a glance
- Drugs Atomoxetine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 11 Dec 2007 Status change from recruiting to completed.
- 23 Jan 2007 New trial record.